RxDoctor Payments DataLook up a doctor →

Elizabeth Sekul, MD

Neurology with Special Qualifications in Child Neurology · Augusta, GANPI 1215048269

Payments from drug & device makers

$57,484in general payments, 2019–2025

Across 407 payments — averaging $141.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$49K
  • UCB, Inc.$1K
  • Sunovion Pharmaceuticals Inc.$804
  • Greenwich Biosciences, Inc.$575
  • Supernus Pharmaceuticals, Inc.$529
  • Neurelis, Inc.$509
  • plus $5K from 39 others

What the payments were for

  • Food & beverage$8,18999%
  • Education$661%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$57,484 in reported general payments places this provider in the 75th percentile of 41 neurology with special qualifications in child neurology providers in Georgia.

See all neurology with special qualifications in child neurology providers in Georgia

Medicare billing

Part B allowed, 2024
$4,143
Medicare patients
29
Services billed
52

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lacosamide11$1,129

Paid to pharmacies, not to this prescriber.

Other neurology with special qualifications in child neurology in Augusta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →